Bibliography Jonas Rutishauser

1. Original articles; peer-reviewed

  1. Schmid C., Rutishauser J., Schläpfer I., Froesch E.R., Zapf J. Intact but not truncated insulin-like growth factor binding-protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: control of IGF signalling by IGFBP-3-specific proteolysis? Biochem Biophys Res Comm 179(1): 579-585, 1991.
  2. Rutishauser J., Schmid C., Hauri C., Froesch E.R., Zapf J. Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo. FEBS Lett 334(1): 23-26, 1993.
  3. Zapf J., Hauri C., Futo E., Hussain M., Rutishauser J., Maack C.A., Froesch E.R. Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats. J Clin Invest 95(1): 179-186, 1995.
  4. Rutishauser J., Böni-Schnetzler M., Böni J., Wichmann W., Huisman T., Vallotton M.B., Froesch E.R. A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 81(1): 192-198, 1996.
  5. Rutishauser J., Kopp P., Gaskill M. B., Kotlar T. J., Robertson G.L. A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal dominant neurohypophyseal diabetes insipidus. Mol Genet and Metab 67: 89-92, 1999.
  6. Beuret N.*, Rutishauser J.*, Bider M.D., Spiess M. Mechanism of ER retention of mutant vasopressin precursor caused by a signal peptide truncation associated with diabetes insipidus. J Biol Chem 274(27): 18965-18972, 1999. *First 2 authors contributed equally.
  7. Rutishauser J., Funke G., Lütticken R, Ruef C. Streptococcal toxic shock syndrome in two patients infected by a colonized surgeon. Infection 27(4/5): 259-260, 1999.
  8. Rutishauser J., Kopp P., Gaskill M.B., Kotlar T.J., Robertson G.L. Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysin II (AVP-NP II) gene. Eur J Endocrinol 146: 649-656, 2002.
  9. Elzi L., Decker M., Battegay M., Rutishauser J., Blum J. Chest pain after travel to the tropic. Lancet 363: 1198, 2004.
  10. Gillam M.P., Sidhaye A.R., Lee E.J., Rutishauser J., Waeber Stephan C., Kopp P. Functional characterization of pendrin in a polarized cell system: evidence for pendrin-mediated apical iodide efflux. J Biol Chem 279(13): 13004-13010, 2004.
  11.  Friberg, M.A., Spiess, M. Rutishauser, J. Degradation of wild-type vasopressin precursor and pathogenic mutants by the proteasome. J Biol Chem 279(19): 19441-19447, 2004.
  12. Beuret N., Stettler H., Renold A., Rutishauser J., Spiess M. Regulated secretory proteins generate granule-like structures when expressed in constitutively secreting cells. J Biol Chem 279(19): 20242-20249, 2004.
  13. Rutishauser J. (principal investigator). Short versus conventional-term glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE trial (Reduction in the Use of Corticosteroids in Exacerbated COPD) ISRCTN19646069. Lancet online: protocol summary 05PRT/17, 2006. (http://www.thelancet.com/protocol-reviews/05PRT-17)
  14. Katan M., Morgenthaler N.G., Dixit K.C.S., Rutishauser J, Brabant G.E., Müller B., Christ-Crain M. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. J Clin Endocrinol Metab 92:260-3643, 2007.
  15. Blum J.A., Schmid C. Hatz C., Kazumba L., Mangoni P., Rutishauser J., Latorre A., Burri C. Sleeping glands ? - The role of endocrine disorders in sleeping sickness (T.b. gambiense human African trypanosomiasis). Acta tropica 104: 16-24, 2007.
  16. Birk J., Friberg M.A., Prescianotto-Baschong C., Spiess M., Rutishauser J. Dominant pro-vasopressin mutants causing diabetes insipidus form disulfide-linked fibrillar aggregates in the endoplasmic reticulum. J Cell Science 22:3994-4002, 2009.
  17. Schuetz P, Leuppi JD, Tamm M, Briel M, Bingisser R, Dürring U, Müller B, Schindler C, Viatte S, Rutishauser J. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease: the “REDUCE” trial. Design and baseline characteristics. Swiss Med Wkly 2010, in press.

2. Reviews

  1. Rutishauser J., Froesch E.R. Signal peptide and neurophysin II gene mutations in hereditary central diabetes insipidus. News in Physiological Sciences (Review) 12: 67-71, 1997.
  2. Rutishauser J., Kopp P. Surprising news: a putative sulfate transporter is defective in Pendred's syndrome. Eur J Endocrinol (Editorial Highlight) 138(6): 623-624, 1998.
  3. Rutishauser J., Kopp P. Aquaporin-2 water channel mutations and nephrogenic diabetes insipidus: new variations on a theme. Eur J Endocrinol (Editorial Highlight) 140: 137-139, 1999.
  4. Rutishauser J., Spiess M. Endoplasmic reticulum storage diseases. Swiss Medical Weekly 132: 211-222, 2002. (invited peer-reviewed review)
  5. Rutishauser J. Die Bedeutung der Statine: Cholesterinsenkung oder auch mehr? Praxis 95: 107-10, 2005.
  6. Rutishauser J. The role of statins in clinical medicine - LDL-cholesterol lowering and beyond. Swiss Medical Weekly 136; 41-9, 2006 (invited peer-reviewed review).
  7. Rutishauser J. Pleiotrope Statineffekte. Schweiz Med Forum 8:187-90, 2008 (invited review).
  8. Balanescu S., Rutishauser J. Diabetes insipidus: Differentialdiagnostik und Therapie. Swiss Med Forum 10(7):123-8, 2009 (invited review).
  9. Rutishauser J. Copeptin: Diagnostischer Parameter, Biomarker, oder beides? Ther Umschau 66(11):731-4, 2009.
  10. Scheuter C, Rutishauser J. Hyponatriämie. Ther Umschau 2010, in press (invited review).

3. Monographs

4. Book Contributions

5. Other original articles

  1. Rutishauser J., Hailemariam S., Weinreich T. The normoglycaemic patient with nephrotic syndrome. Nephrol Dial Transpl 13: 1585-1587, 1998.
  2. Otth C., Biedermann B., Engel H., Rutishauser J. Fieber, Odynophagie und Diarrhoe - antibiotikaresistent. Swiss Medical Forum (Coup d'oeil) 26:686-7, 2001
  3. Kneubühl A., Rutishauser J. Kopfschmerzen und transiente homonyme Hemianopsie. Swiss Medical Forum (Coup d'oeil) 40:1000-1, 2001
  4. Weber P., Lütschg J., Rutishauser J. Epilepsia partialis continua und metastaseninduzierte Hyperkalzämie bei einem Mamma-Karzinom. Z. Epileptol 2002; 15: 102-5
  5. Peters F., Cathomas G., Thurnheer R., Rothen M., Rutishauser J. Simultaneous bilateral spontaneous pneumothorax in a patient with recurrent, extraosseous multiple myeloma. Postgraduate Medical Journal 79:106-7, 2003.
  6. Burri E., Rüegg S., Rutishausr J., Lampert M.L. Subtherapeutic levels of phenytoin due to a medication error. Praxis 96: 687-92, 2007.
  7. Groeschl I., Kos S., Rutishauser J. Hormone-inactive pituitary macroadenoma: an uncommon cause for the syndrome of inappropriate antidiuresis. Exp Clin Endocrinol Diabetes 116: 268-71, 2008.
  8. Various short articles on landmark publications in molecular medicine, published in Swiss Medical Forum under "biomed.com" (separate bibliography on file)